PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Chain Reaction Ltd.

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04L (Transmission OF Digital Information, e.g. Telegraphic Communication).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Chain ranks #45,585 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#45,585
of 49,997 US assignees by volume
Top 19%
by Innovation Score (47.3/100)
28.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R45585 · Foreign Corporation #45,585 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #45,585/49,997
  • PHOTO-FINISH CG Oncology
  • CPC-NARROW H04L · 3 areas
  • INNOV-PAR 47.3/100
  • CLAIMS-DENSE 28.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2024–2025 · 2y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: CG Oncology, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Chain

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Chain's Innovation Score is 47.3/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Chain's grants concentrate

Chain Reaction Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under H04L (Transmission OF Digital Information, e.g. Telegraphic Communication). By volume, Chain sits between CG Oncology, Inc. and Chang YOW Technologies International Co., Ltd..

Chain's three-year grant acceleration

Chain Reaction Ltd. shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Chain's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Chain holds 5 patents at rank #45,497, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Chain

By rank, the assignees closest to #45,497 in granted patent volume.

Leaders in H04L (Transmission OF Digital Information)

Other assignees with the most granted patents in Chain's primary technology class.

Chain's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1.522.533.5 20242025 2
USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table
Chain Reaction Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2024 3 60.0%
2025partial year 2 40.0%

Which technologies does Chain Reaction Ltd. patent most?

Top 3 of 3 technology areas

Where it ranks

Overall rank by patents

#45,585

of 49,997 tracked assignees

Innovation Score

47.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Chain Reaction Ltd.'s patent record in context - here's where to go next.

  • Chain Reaction Ltd.'s lead technology class is H04L (Transmission OF Digital Information, e.g. Telegraphic Communication), 100% of its portfolio - see every assignee active in that class. Explore H04L
  • Ranked #45,585 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Chain Reaction Ltd. against CG Oncology, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 47.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.